"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust...

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the..